Novasep’s outstanding results in scale-up and biomanufacturing of Apo-A1 acknowledged by Cerenis at BioProcess...
Novasep, a leading provider of purification-based manufacturing solutions for lifescience molecules, announces today that...
Pharma Rural Marketing India 2012 – India’s most comprehensive conference on pharmaceutical marketing in...
India is the world's fourth largest pharmaceutical market in terms of volume and ranks fifteen...
According to PricewaterhouseCoopers, the Indian pharmaceutical market is expected to grow from US$11 billion...
According to PricewaterhouseCoopers, the Indian pharmaceutical market is expected to grow from US$11 billion to...
Immutep and Lonza sign agreement for cell line selection, cell banking and process development...
Immutep and Lonza announced today an agreement for cell line selection, master cell banking and...
Novasep opens new 2,000 m2 expanded Shanghai facilities to meet increasing East Asia demand
Novasep, a leading supplier of manufacturing solutions to the life sciences industries, today announces...
N3D Unveils the Next Generation of 3D Cell Culturing System
Only days after Rainbow BioSciences closed a deal to acquire an equity interest in Nano3D...
Rhenovia launches drug discovery programs in rare, orphan and neglected neurodegenerative diseases
Rhenovia Pharma, a leading biotech company in biosimulation applied to the discovery of new medications...
AstraZeneca files lawsuit against the FDA for decision regarding quetiapine product labelling and exclusivity
AstraZeneca today filed a lawsuit against the US Food and Drug Administration (FDA) in...
Boehringer Ingelheim expands capabilities in biopharmaceutical process science
Ingelheim, Germany – Boehringer Ingelheim has expanded its biopharmaceutical development and manufacturing capabilities at...
Cytheris announces results of phase II study indicating that recombinant Interleukin-7 (CYT107) expands CD4...
Cytheris SA, a clinical stage biopharmaceutical company focused on development of new therapies for immune...
